Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative

AbstractHepatocellular carcinoma (HCC) with bile duct tumor thrombus (BDTT) formation is a rare entity found microscopically in 1% to 9.2% of resected specimens. The ideal treatment for HCC is surgical resection. However, because of poor hepatic functional reserve in patients with HCC, most tumors are unresectable. Here, we report 2 cases of HCC with BDTT type III accompanied by hepatic dysfunction that were successfully treated with radiofrequency (RF) ablation. We used RF ablation as both a radical therapeutic method and an efficient way to control bleeding from the origin of BDTT after BDTT removal. At the time of writing, the 2 patients have been disease-free for 16 and 12 months, respectively.Our results show that RF ablation may be used as a radical therapeutic alternative for HCC with BDTT in patients with liver cirrhosis and obstructive jaundice.

[1]  K. Tanabe,et al.  The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence‐based comparison and review , 2014, Cancer.

[2]  Bi-ling Liang,et al.  Small hepatocellular carcinoma with bile duct tumor thrombi: CT and MRI findings , 2010, Abdominal Imaging.

[3]  A. Tanaka,et al.  Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi. , 1994, Hepato-gastroenterology.

[4]  T. Takayama,et al.  Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case , 2013, World Journal of Surgical Oncology.

[5]  Shinpei Sato,et al.  Percutaneous radiofrequency ablation for hepatocellular carcinoma , 2005, Cancer.

[6]  Lang Li,et al.  Diagnosis of bile duct hepatocellular carcinoma thrombus without obvious intrahepatic mass. , 2010, World journal of gastroenterology.

[7]  Wenbing Sun,et al.  Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment. , 2015, World journal of gastroenterology.

[8]  Zheng Wu,et al.  Caution for Diagnosis and Surgical Treatment of Recurrent Cholangitis , 2014, Medicine.

[9]  Y. Joo,et al.  Acute obstructive cholangitis complicated by tumor migration after transarterial chemoembolization: a case report and literature review. , 2014, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[10]  A. Cárdenas,et al.  Bile duct hepatocellular carcinoma thrombi. , 2012, Gastroenterologia y hepatologia.

[11]  W. Helton,et al.  Minimizing complications with radiofrequency ablation for liver cancer: the importance of properly controlled clinical trials and standardized reporting. , 2004, Annals of surgery.

[12]  Wu Mengchao,et al.  Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities , 2009, Langenbeck's Archives of Surgery.

[13]  D. Sinn,et al.  Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy , 2014, Medicine.

[14]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.